Persistent problems with standardization of immunoassays for anti-cardiolipin antibodies

Thrombosis and Haemostasis

Volumn 86, Issue 4, 2001, Pages 1123-1124

  Fontaine, M ^a   Homburger, H A ^a   Nichols, W L ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ABSORPTION; ANTIPHOSPHOLIPID SYNDROME; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; IMMUNOCHEMISTRY; INTERMETHOD COMPARISON; LETTER; MAJOR CLINICAL STUDY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; SERUM CHARACTERISTICS; STANDARDIZATION; THROMBOSIS;

EID: 0034759385     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616548     Document Type: Letter

References (6)

1. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome
2. The second international anticardiolipin workshop / the Kingston anti-phospholipid antibody study (KAPS) group
3. Rapid detection of anticardiolipin antibodies
4. Criteria for the diagnosis of lupus anticoagulants: An update
5. The prevalence of vascular occlusive disease associated with antiphospholipid syndromes
6. Diagnosis of the antiphospholipid syndrome: A proposal for use of laboratory tests